Caseware UK (AP4) 2023.0.135 2023.0.135 2024-08-312024-08-312025-05-22No description of principal activity2023-09-01false1010truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 05513085 2023-09-01 2024-08-31 05513085 2022-09-01 2023-08-31 05513085 2024-08-31 05513085 2023-08-31 05513085 c:Director1 2023-09-01 2024-08-31 05513085 d:MotorVehicles 2023-09-01 2024-08-31 05513085 d:MotorVehicles 2024-08-31 05513085 d:MotorVehicles 2023-08-31 05513085 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-09-01 2024-08-31 05513085 d:FurnitureFittings 2023-09-01 2024-08-31 05513085 d:FurnitureFittings 2024-08-31 05513085 d:FurnitureFittings 2023-08-31 05513085 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-09-01 2024-08-31 05513085 d:OwnedOrFreeholdAssets 2023-09-01 2024-08-31 05513085 d:Goodwill 2023-09-01 2024-08-31 05513085 d:Goodwill 2024-08-31 05513085 d:Goodwill 2023-08-31 05513085 d:CurrentFinancialInstruments 2024-08-31 05513085 d:CurrentFinancialInstruments 2023-08-31 05513085 d:CurrentFinancialInstruments 1 2024-08-31 05513085 d:CurrentFinancialInstruments 1 2023-08-31 05513085 d:Non-currentFinancialInstruments 2024-08-31 05513085 d:Non-currentFinancialInstruments 2023-08-31 05513085 d:CurrentFinancialInstruments d:WithinOneYear 2024-08-31 05513085 d:CurrentFinancialInstruments d:WithinOneYear 2023-08-31 05513085 d:Non-currentFinancialInstruments d:AfterOneYear 2024-08-31 05513085 d:Non-currentFinancialInstruments d:AfterOneYear 2023-08-31 05513085 d:ShareCapital 2024-08-31 05513085 d:ShareCapital 2023-08-31 05513085 d:RetainedEarningsAccumulatedLosses 2024-08-31 05513085 d:RetainedEarningsAccumulatedLosses 2023-08-31 05513085 c:FRS102 2023-09-01 2024-08-31 05513085 c:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 05513085 c:FullAccounts 2023-09-01 2024-08-31 05513085 c:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 05513085 d:AcceleratedTaxDepreciationDeferredTax 2024-08-31 05513085 d:AcceleratedTaxDepreciationDeferredTax 2023-08-31 05513085 f:PoundSterling 2023-09-01 2024-08-31 iso4217:GBP xbrli:pure

Registered number: 05513085










ALPHARM CHEMIST LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 AUGUST 2024

 
ALPHARM CHEMIST LIMITED
REGISTERED NUMBER: 05513085

STATEMENT OF FINANCIAL POSITION
AS AT 31 AUGUST 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 5 
47,308
52,624

  
47,308
52,624

Current assets
  

Stocks
  
30,227
36,502

Debtors: amounts falling due within one year
 6 
77,343
80,396

Cash at bank in hand
  
41,486
33,746

  
149,056
150,644

Creditors: amounts falling due within one year
 7 
(152,046)
(134,628)

Net current (liabilities)/assets
  
 
 
(2,990)
 
 
16,016

Total assets less current liabilities
  
44,318
68,640

Creditors: amounts falling due after more than one year
 8 
(25,688)
(38,514)

Provisions for liabilities
  

Deferred tax
 9 
(11,461)
(10,904)

  
 
 
(11,461)
 
 
(10,904)

Net assets
  
7,169
19,222


Capital and reserves
  

Called up share capital 
  
400
400

Profit and loss account
  
6,769
18,822

  
7,169
19,222


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Page 1

 
ALPHARM CHEMIST LIMITED
REGISTERED NUMBER: 05513085
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 AUGUST 2024

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 22 May 2025.




Mr M Vaiya
Director

The notes on pages 3 to 9 form part of these financial statements.

Page 2

 
ALPHARM CHEMIST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

1.


General information

Alpharm Chemist Limited is a private company, limited by share capital and incorporated in England and Wales under registration number 05513085. The address of the registered office of the company is Level 5A, Maple House, 149 Tottenham Court Road, London, W1T 7NF.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Page 3

 
ALPHARM CHEMIST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)

 
2.4

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Income Statement in the same period as the related expenditure.

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


Page 4

 
ALPHARM CHEMIST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)

 
2.7

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

Goodwill
-
10
years



 
2.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Delivery vehicle
-
25%
reducing balance
Fixtures and fittings
-
15%
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.9

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.10

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 5

 
ALPHARM CHEMIST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)

 
2.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.12

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 10 (2023 - 10).


4.


Intangible assets




Goodwill

£



Cost


At 1 September 2023
155,000



At 31 August 2024

155,000



Amortisation


At 1 September 2023
155,000



At 31 August 2024

155,000



Net book value



At 31 August 2024
-



At 31 August 2023
-



Page 6

 
ALPHARM CHEMIST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

5.


Tangible fixed assets





Delivery car
Fixtures & fittings
Total

£
£
£



Cost or valuation


At 1 September 2023
9,900
151,733
161,633


Additions
-
3,115
3,115



At 31 August 2024

9,900
154,848
164,748



Depreciation


At 1 September 2023
9,206
99,803
109,009


Charge for the year on owned assets
174
8,257
8,431



At 31 August 2024

9,380
108,060
117,440



Net book value



At 31 August 2024
520
46,788
47,308



At 31 August 2023
694
51,930
52,624


6.


Debtors

2024
2023
£
£


Trade debtors
68,917
71,957

VAT repayable
7,808
8,143

Prepayments and accrued income
618
296

77,343
80,396


Page 7

 
ALPHARM CHEMIST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank overdrafts
8,124
-

Bank loan
13,348
13,459

Trade creditors
93,479
80,967

Corporation tax
20,571
17,816

Other taxation and social security
1,226
-

Directors loan account
5,840
9,173

Accruals
-
3,500

Pension payable
681
648

Wages payable
8,777
9,065

152,046
134,628


The bank loan is secured by a fixed and floating charge over the assets of the company.


8.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loan
25,688
38,514

25,688
38,514


The bank loan is secured by a fixed and floating charge over the assets of the company.


9.


Deferred taxation




2024


£






At beginning of year
(10,904)


Charged to profit or loss
(557)



At end of year
(11,461)

Page 8

 
ALPHARM CHEMIST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024
 
9.Deferred taxation (continued)

The provision for deferred taxation is made up as follows:

2024
2023
£
£


Accelerated capital allowances
(11,461)
(10,904)

(11,461)
(10,904)


10.


Controlling party

The company was under the control of the directors Mr M Vaiya (38% share) and Mrs G Vaiya (32% share), by virtue of the fact that they own 70% of the issued share capital between them.

 
Page 9